Assay+ COVID-19 antigen rapid test is authorized with CE marker, the sensitivity is 90%, the specificity is 98.5%. Assay+ Covid 19 antigen rapid test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein of SARS-CoV-2 from the nasopharyngeal swab from the suspected COVID-19 patients within five days of symptom onset. This test is an aid to differentiate Covid 19 virus infection from other respiratory tract infection caused by coronavirus 229E, NL63, OC43 and HKU1, or severe acute respiratory syndrome caused by SARS-CoV and MERS-CoV. The test should be performed in moderate, high or waived complexity tests. This test can also perform for the Point of Care (POC) purpose.
Assay+ Syphilis ntibody rapid test is manufactured in Canada to detect specific syphilis IgG for the healthcare providers. Assay+ syphilis Rapid Test Kit is qualitative test device for syphilis antibodies from human serum or plasma,. This device has been OEM over one million for our customers. Sensitivity over 95% syphilis infected patients, and 100% specificity have been proved used by our customers in large quantity.
Assay+ HBV surface antigen rapid test is manufactured in Canada to detect HBV surface antigen for the healthcare providers. Assay+ HBV surface antigen Rapid Test Kit is qualitative test device for HBV antigen in human serum, plasma, whole blood. This device has been used by our end customers with large quantity. Sensitivity over 95% and 100% specificity have been proved used by our customers in large quantity.
Rapid SAR-CoV-2 (Covid-19) Test Kits: FDA & CE Approved (Results in 15 min). SAR-CoV-2 IgG/IgM Rapid Test Cassette is a qualitative membrane based immunoassay for the detection of IgG and IgM antibodies to SAR-CoV-2 in human whole blood, serum or plasma specimen. Made in China: FDA and CE Approved, China NMPA approval (export allowed) One of the earliest CE (Feb 2020) and FDA (Mar 2020) approved kit. Clinically studied and reliable. Packaging: 20 sets/box or 40 sets/box. Payment term: MOQ 2000 sets, FOB China $ 9.5/set. < 10000 sets 100% advance payment > 10000 sets L/C ex-work on site
Rapid SAR-CoV-2 (Covid-19) Test Kits: FDA & CE Approved (Results in 15 min). SAR-CoV-2 IgG/IgM Rapid Test Cassette is a qualitative membrane based immunoassay for the detection of IgG and IgM antibodies to SAR-CoV-2 in human whole blood, serum or plasma specimen. Made in China: FDA and CE Approved, China NMPA approval (export allowed) One of the earliest CE (Feb 2020) and FDA (Mar 2020) approved kit. Clinically studied and reliable. Packaging: 20 sets/box or 40 sets/box. Payment term: MOQ 2000 sets, FOB China $ 9.5/set. < 10000 sets 100% advance payment > 10000 sets L/C ex-work on site
1. Principle This kit is based on the specific reaction of antibody-antigen and immunochromatography. β-lactam and tetracyclines antibiotics in the sample compete for the antibody with the antigen coated on the membrane of the test strip. Then after a color reaction, the result can be observed. 2. Applications This kit is used for rapid qualitative analysis of β-lactam and tetracyclines in milk sample.
Highest accuracy Fast result interpretation Cost effective Made with best choices of materials Type: immunoassay system Brand name: ntbio/oem/private label Place of origin: british columbia, canada Size: 60mm x 300mm Accuracy: 99.9% Sensitivity: 20 miu/ml Specimen: urine .
We have just achieved a major breakthrough in the development of dengue igg/igm antibody early test. Our new product is capable to detect the presence of dengue igm antibody in human serum within 3-5 days since primary infection (tested and verified with reference standard blood sample from usa cdc), while similar products currently found on the market can only detect it after at least 10-15 days. The significance of this achievement is that the new dengue igg/igm antibody early test now can diagnose dengue infection at a very early stage, which previously could only be done with a dengue ns1 antigen test. Type: immunoassay system Brand name: ntbio/oem/private label Place of origin: british columbia, canada Size: 60mm x 300mm Sensitivity: 95.3% Specificity: 95.0% Specimen: whole blood/serum/plasma .
Highest accuracy Fast result interpretation Cost effective Made with best choices of materials Type: immunoassay system Brand name: ntbio/oem/private label Place of origin: british columbia, canada Size: 60mm x 300mm Sensitivity: 94.3% Specificity: >98.9% Specimen: whole blood/serum/plasma .
Highest accuracy Fast result interpretation Cost effective Made with best choices of materials Type: immunoassay system Brand name: ntbio/oem/private label Place of origin: british columbia, canada Size: 60mm x 300mm Accuracy: 99.9% Sensitivity: 20 miu/ml Specimen: urine .
Highest accuracy Fast result interpretation Cost effective Made with best choices of materials Type: immunoassay system Brand name: ntbio/oem/private label Place of origin: british columbia, canada Size: 60mm x 300mm Cut-off value: 1000 ng/ml Sensitivity: 99.5% Specificity: >99.7% Specimen: urine .
selling all ppe products from N95 masks KN95 masks masks 3ply masks gloves covid tests
Singclean COVID-19 Test Kit (Colloidal Gold Method) is a solid phase immunochromotographic assay for the rapid, qualitative detection of antigen from COVID-I 9 in human nasal swab specimen. This test provides only a preliminary test result. Therefore, any reactive specimen with the COVID-19 Test Kit (Colloidal Gold Method) must be confirmed with alternative testing method(s) and clinical findings. Features: Results ready in 15 minutes Accurate diagnostic tool for active infection Easy to administer and read results Affordable, no need for instrument, highly portable Enable testing on a massive scale Storage and Stability The kit can be stored at room temperature or refrigerated (4-30�°C). The test device is stable through the expiration date printed on the sealed pouch. The test device must remain in the sealed pouch until use. Do not freeze. Do not use beyond the expiration date. Limitation: 1. Use fresh samples whenever possible. 2. Positive results do not rule out bacterial infection or co-infection with other viruses. 3. A negative result can occur if the quantity of the COVID-19 antigen present in the specimen is below the detection limits of the assay, or failed to collect the COVID-19 antigen in the nasal cavity of the patient. 4. Negative results do not rule out infection with COVID-I 9 and should not be used as the final of sole basis for treatment or patient management decisions. Negative results should be considered in the context of a patients recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-I 9. For a more accurate test result, repeat the tests or confirmed with other testing methods and clinical findings is recommended. Warnings: Optimal assay performance requires strict adherence to the assay procedure described in this insert sheet. Inadequate of inappropriate sample collection, storage, and transport may cause false test results.
A pack of 100 or 200 medium sized saturated alcohol swabs. Made using USP grade 70% isopropyl alcohol. Meets all Health Canada requirements. Each swab is individually sealed and disposable for convenience and safety.
